Eli Lilly Stocks Move Higher Before GLP-1 Mix Test
Published . Updated .
This report is about the broad US market.
Directly affected
- LLY Eli Lilly+12.6% 30d
Named in this report.
Indirectly affected
- DIA SPDR Dow Jones Industrial Average ETF-1.7% 30d
SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- QQQ Invesco QQQ+1.7% 18d
Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Eli Lilly and belongs to, so it often moves with news about it.
- JNJ Johnson & Johnson+0.5% 30d
Johnson & Johnson is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+9.1% 30d
AbbVie is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck-2.1% 15d
Merck is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories-2.0% 30d
Abbott Laboratories is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- PFE Pfizer+8.4% 30d
Pfizer is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| LLY | -2.64% | -0.26% | base | +0.41% | +0.67% | +0.34% | after close |
| DIANo price data for this ticker | — | — | — | — | — | — | — |
| QQQ | +2.00% | +2.99% | base | +1.12% | +2.57% | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| ABBVNo price data for this ticker | — | — | — | — | — | — | — |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
| ABTNo price data for this ticker | — | — | — | — | — | — | — |
| PFENo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Eli Lilly Stocks Move Higher Before GLP-1 Mix Test Yahoo Finance UK
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| LLY | that day | +0.41% | final price |
| LLY | the next day | +0.67% | final price |
| LLY | two days later | +0.34% | still updating |
| LLY | three days earlier | -0.26% | final price |
| LLY | five days earlier | -2.64% | final price |
| QQQ | that day | +1.12% | final price |
| QQQ | the next day | +2.57% | final price |
| QQQ | three days earlier | +2.99% | final price |
| QQQ | five days earlier | +2.00% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 52 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 31 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 48 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 52 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 42 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 52 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought AbbVie (ABBV), worth $50,001 - $100,000 on 31 Jul 2026. That is 87 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 32 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 68 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 87 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 38 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 52 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid “Eli Lilly Stocks Move Higher Before GLP-1 Mix Test” looks
12 out of 100Price not final
“Eli Lilly Stocks Move Higher Before GLP-1 Mix Test” scores 12 out of 100. The score uses 1 sources. The price is not final yet.